Chondrogenic and hypertrophic signaling pathways in cartilage and intervertebral disc

The chondrogenic and hypertrophic signaling pathways represent a complex regulatory network governing the life cycle of chondrocytes in articular cartilage and the intervertebral disc (IVD). Chondrogenic signaling, mediated by factors such as TGF-beta, BMPs, and the transcription factor SOX9, is vital for the synthesis of the cartilaginous extracellular matrix (ECM) and the maintenance of tissue integrity (Thielen et al., 2019). In contrast, hypertrophic signaling, characterized by the activation of RUNX2, Wnt/beta-catenin, and Indian Hedgehog (Ihh) pathways, drives chondrocytes toward terminal differentiation, matrix calcification, and apoptosis (van der Kraan & van den Berg, 2012). In degenerative conditions like osteoarthritis (OA) and intervertebral disc degeneration (IVDD), a pathological shift toward hypertrophy occurs, leading to the upregulation of matrix metalloproteinases (e.g., MMP13) and the degradation of the functional ECM (Wang et al., 2020). Therapeutic interventions targeting these pathways seek to restore homeostatic balance by either stimulating anabolic chondrogenic signals or suppressing catabolic hypertrophic transitions. Because this entry describes a broad set of biological processes rather than a single molecular entity, it is classified as a pathway set rather than a specific therapeutic target.

Other names

Chondrocyte differentiation pathwaysCartilage hypertrophy signalingIVD degeneration pathwaysChondrogenic regulatory network

Modulation of specific nodes within the chondrogenic or hypertrophic signaling cascades (e.g., TGF-beta, Wnt, BMP, FGF) to promote extracellular matrix synthesis or inhibit terminal differentiation and degradation.